Atlas Trials

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Clinical trial NCT00033540 · COMPLETED

Trial details

NCT number
NCT00033540
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extrahepatic Bile Duct CancerGallbladder Cancer
Start date
2003-09-01
Primary completion
2008-04-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.